A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer

類似資料

• A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
  著者:: Khan, O A, 等
  出版事項: (2008)
• A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma
  著者:: Kefford, R F, 等
  出版事項: (2009)
• O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
  著者:: Watson, A J, 等
  出版事項: (2009)
• A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
  著者:: Calegari, M A, 等
  出版事項: (2017)
• A phase II study of the PARP Inhibitor, veliparib plus temozolomide in patients with heavily pretreated, metastatic colorectal cancer
  著者:: Pishvaian, Michael J., 等
  出版事項: (2018)